Pathological circuit function is at the origin of many symptoms of neurological disorders. The optogenetic toolbox applied to animal models of behavioral diseases has in the last years led to decisive progress with the hope that deep brain stimulation (DBS) may be used for rational treatments.
OptoDBS 2017, that will take place on June 22 to 24, 2017, at the Campus Biotech in Geneva, will discuss the state of the art of current therapies for DBS and ask how a better understanding of neural circuit dysfunction in pathology could inspire novel protocols. A particular emphasis will be on novel DBS indications such as obsessive compulsive disorders (OCD), depression or addiction. Cutting-edge optogenetic presentations will interleave with clinical studies from leading experts.
Organizers: Paul Krack and Christian Lüscher.